News Coverage for Technologies Scan Corp. (OTCQB: TENP) - August 26, 2013

Stock News

  • Last Trade: $
  • Change:
  • Open: $
  • High: $
  • Low: $
  • Volume:

Company Snapshot
Technologies Scan Corp.

331 Labelle
St-Jerome, QC J7Z 5L2

Ghislaine St-Hilaire, President
Gilbert Pomerleau CFO, Treasurer
Tel: 450-504-6923

Ticker Symbol: TENP
Exchange: OTCQB
Shares Outstanding: 117,650,000
Float: APX 37,150,000 +/-

52 Week Low: $0.01
52 Week High: $0.243


Investors Links
TENP Message Boards
Investors Hub

TENP Mobi Site
Never miss news alerts from

Text PRESS to 545454 for
Free News Alerts


Technologies –Scan Corp announces upcoming USA launch for its Proteina21 weight loss product line

Montreal, Canada, August 26, 2013, Technologies –Scan Corp ( OTCQB: TENP ) is pleased to announce the upcoming USA launch of its Proteina21 product line scheduled for November 1 2013 thus entering the 66 billion dollar USA weight loss market. The company has ordered thru Social Geek Media, it’s licensor of the Proteina21 license for the USA, the necessary product inventory for its initial USA launch.

Get News Alerts & Stock Updates for Technologies Scan delivered directly to your Mobile Phone. Text PRESS to 545454 (News alerts are free; however standard message & data rates may apply. Check with your carrier for more details.)

TENP AlertslProteina21 is a product line of food supplements and readymade meals high in protein and low in carbohydrates designed to help people lose weight. The Proteina21 product line will consist of several different weight loss products. The products are shipped overnight and are available thru internet sales on their website

About Technologies-Scan Corp (OTCQB: TENP)
Technologies-Scan Corp is database management company specializing in the development of several internet base software applications for the health and consumer wellbeing markets. The company signed an exclusive USA marketing and distribution license for the Proteina21 weight loss products line.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.

Technologies-Scan Corp
Investor relations

About Technologies Scan Corp. (OTCQB: TENP)

Discover a fast growing company

We are a development stage company whose plan of operation is selling and distributing health products, including a health database
TENP Alerts system. We have developed an exhaustive database and software for natural health products. We believe our Medicus21software is a unique information provider of natural health products to be used through a mobile application and barcode reader. It enables the user to scan any natural health product’s bar code, through the help of their smart phone, and instantly obtain all nutritional information, use, benefits and a plethora of information on the product.

Our Joint Venture with SGM includes the design, technologies, how to, development, production and sale of nutritional, protein and dietary supplements online. All Proteina21 products have common features, including:

1) A flavor, taste and format tailored to market needs;
2) Quick and easy preparation;
3) Scientific formulation;
4) Rigorous manufacturing standards.


Proteļna21 specializes in the development and marketing of protein-based food products and supplements.

The company has enjoyed rapid growth over the last year, steadily making a name for itself around the Canada.

We do not limit ourselves to purely commercial objectives: our primary goal is to help people lose weight and keep it off, all the while respecting nutrition and medical ethics.

A dynamic team

In order to provide our customers with the very best of weight loss products, we have gathered a team of young and dynamic specialists.

Our research and development department is working hard to deliver quality products that meet the needs of a modern clientele. It is supported in this task by the raw material purchasing department.

We at Proteļna21 care about our customers’ satisfaction - this is why our customer service is always there to assist you and answer your questions. "Easy and clear communication is essential to mutual understanding" - this policy allows us to provide our customers with the quality of service they deserve.

A dedicated production team

Our production team is at the heart of the company’s operations – the strictest rules of hygiene are respected to ensure the high quality of the final product. Additionally, our quality control department guarantees the safety of our products, from reception of raw materials to shipping in compliance with the requirements of the Canadian Food Inspection Agency.

Our management staff is composed of experts with many years of experience - whether they’re working in technical management, public relations, general management, accounting, or technical writing.

Research and Development

In order to improve existing products and create new ones, Proteļna21 focuses on research and development. This constant investment allows the company to maintain a leading position in its field and to enjoy record-breaking achievements in both quality and productiveness.

Creating great-tasting food products (and especially dietary products) requires many months of hard work; each formulation is carefully researched and improved to make the product a leader in its category in terms of flavor and quality.

Once a product has been produced, it undergoes a battery of tests (quality control, nutritional analysis, microbiological and organoleptic tests). All products are manufactured in strict compliance with the prescribed standards and norms of the industry.

Proteļna21’s leading managers are committed to creating mouthwatering protein and dietary products and supplements that will spark the consumers’ interest. Over the next few years, the company plans on expanding its product line even further in order to offer even more flavors and weight-loss delights to its customers.


Recent Technologies Scan Corp. (OTCQB: TENP)

Technologies-Scan Corp Launches Updated Website to Reflect New Distribution and License Agreement With Proteina21 Weight Loss Product Line

MONTREAL, QUEBEC, Jun 05, 2013 (Marketwired via COMTEX) -- Technologies-Scan Corp (OTCQB: TENP) updates its current website to reflect the new sales and distribution agreement with Proteina21 weight loss product line. "The new website is designed to better reflect what we are doing with Proteina21" says CEO Patrick Aube." Having myself a strong background in internet sales and technology, updating the website was a priority for me when we signed the license agreement for the weight loss product line. It is the corner stone of our business model and thus special attention must be put on this aspect of the business" added Aube. The website will reflect the new direction the company is going with the online Proteina21 weight loss products. TENP Alerts
Technologies-Scan Corp owns an exclusive distribution, sales and marketing license for Proteina21 weight loss products for the US market and options on Canadian and European markets.

Proteina21 is a product line of food supplements and readymade meals high in protein and low in carbohydrates designed to help people lose weight. The products are shipped overnight and are available thru internet sales on their website at


Technologies-Scan Corp Announces the Nomination of Patrick Aube as New CEO

MONTREAL, QUEBEC, May 29, 2013 (Marketwired via COMTEX) -- Technologies-Scan Corp (OTCQB: TENP) is proud to announce the nomination of Patrick Aube as new CEO. "This move was part of the plan when we signed the license agreement," says Ghislaine St-Hilaire, the now former CEO. "Patrick Aube is a serial entrepreneur with over 18 years experience in computer technologies and Internet sales, his expertise will greatly benefit the company and shareholders, Patrick is a recognized Internet marketing expert and author of a bestselling book sold in 40 countries on all you need to know to generate income on the Internet and was nominated as Entrepreneur of the Year in the prestigious Ernst & Young 2010 contest," added St-Hilaire.
Aube created Social Media Geek Inc and operates the popular website, one of the largest French-speaking websites in the world, with over one million unique visitors every month. Social Media Geek also specializes in database technology and media social networks.

Technologies-Scan Corp owns an exclusive distribution, sales and marketing license for Proteina21 weight loss products for the US market, and options for Canadian and European markets.


FN Media Disclaimer

FN Media Group LLC (FNMG) owns and operates (FNM) is a third party publishing provider which disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For services performed FNMG has been compensated one thousand five hundred dollars for coverage on this TENP news release by a non-affiliated third party. FNMG HOLDS NO SHARES OF Technologies Scan Corp. (OTCQB: TENP)

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.